Cholangiocarcinoma

被引:1103
作者
Khan, SA
Thomas, HC
Davidson, BR
Taylor-Robinson, SD
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Med, Liver Unit, London, England
[2] Royal Free Hosp, Dept Surg, London NW3 2QG, England
关键词
D O I
10.1016/S0140-6736(05)67530-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to diagnose, and is associated with a high mortality. The incidence of intrahepatic cholangiocarcinoma is increasing worldwide. The cause for this rise is unclear, although it could be related to an interplay between predisposing genetic factors and environmental triggers. MRI and CT with endoscopic ultrasound and PET provide useful diagnostic information in certain patients. Surgical resection is the only chance for cure, with results depending on careful technique and patient selection. Data suggest that liver transplantation could offer long-term survival in selected patients when combined with neoadjuvant chemoradiotherapy. Chemotherapy and radiotherapy have been ineffective for patients with inoperable tumours. For most of these patients biliary drainage is the mainstay of palliation. However, controversy exists over the type and positioning of biliary stents. Photodynamic treatment is a new palliative technique that might improve quality of life.
引用
收藏
页码:1303 / 1314
页数:12
相关论文
共 129 条
  • [111] Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998
    Taylor-Robinson, SD
    Toledano, MB
    Arora, S
    Keegan, TJ
    Hargreaves, S
    Beck, A
    Khan, SA
    Elliott, P
    Thomas, HC
    [J]. GUT, 2001, 48 (06) : 816 - 820
  • [112] THAMAVIT W, 1978, CANCER RES, V38, P4634
  • [113] BSEP: Function and role in progressive familial intrahepatic cholestasis
    Thompson, R
    Strautnieks, S
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (04) : 545 - 550
  • [114] Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
    Thongprasert, S
    Napapan, S
    Charoentum, C
    Moonprakan, S
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (02) : 279 - 281
  • [115] Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma
    Todoroki, T
    Ohara, K
    Kawamoto, T
    Koike, N
    Yoshida, S
    Kashiwagi, H
    Otsuka, M
    Fukao, K
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (03): : 581 - 587
  • [116] Tullo A, 2000, EUR J CLIN INVEST, V30, P798
  • [117] Intrahepatic peripheral cholangiocarcinoma:: CT evaluation
    Valls, C
    Gumà, A
    Puig, I
    Sanchez, A
    Andía, E
    Serrano, T
    Figueras, J
    [J]. ABDOMINAL IMAGING, 2000, 25 (05): : 490 - 496
  • [118] Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma
    van Leeuwen, DJ
    Reeders, JWAJ
    [J]. ANNALS OF ONCOLOGY, 1999, 10 : 89 - 93
  • [119] FIC1 disease: A spectrum of intrahepatic cholestatic disorders
    van Mil, SWC
    Klomp, LWJ
    Bull, LN
    Houwen, RHJ
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (04) : 535 - 544
  • [120] RECENT ADVANCES IN THE MANAGEMENT OF CHOLANGIOCARCINOMAS
    VAUTHEY, JN
    BLUMGART, LH
    [J]. SEMINARS IN LIVER DISEASE, 1994, 14 (02) : 109 - 114